By Kelly Stewart
Manufacturing processes play a critical role in ensuring the safety and efficacy of cutting-edge cell and gene therapy treatments. One emerging technology that has garnered significant attention in recent years is the use of manufacturing execution systems (MES) to optimize cell and gene therapy (CGT) . It does this by providing real-time monitoring and control of production processes, cloud-based MES can enhance the quality and consistency of these new therapies, as well as streamline manufacturing workflows and reduce costs.
This in-depth introduction to MES for CGT manufacturers explores the underlying science behind this technology and the value it can bring to these two fields.